To improve and advance public health by accelerating innovations through creative collaborations that harness the best science.
To offer excellence and innovation in strategic leadership, collaboration, coordination, and infrastructure development, ensuring FDA continues to have a strong regulatory science foundation.
- Support high-quality, collaborative scientific activities to address important public health and regulatory issues concerning FDA regulated products, including their evaluation, quality, safety and effectiveness
- Support core scientific capacity and infrastructure
- Foster development and use of innovative technologies in product development and evaluation
- Address scientific and public health priorities through support of high-quality, peer-reviewed scientific research programs, within and outside FDA.
- Support scientific outreach and research collaboration activities that advance FDA's mission through engaging other agencies, global regulatory partners, academia, innovators, and consumers
- Seek input from FDA programs, stakeholders, and outside advisors, including the FDA Science Board to help define, review and meet FDA scientific needs and priorities
Resources For You
- Advancing Regulatory Science Initiative
- 2022: Advancing Regulatory Science at FDA: Focus Areas of Regulatory Science
- Regulatory Science Extramural Research and Development Projects
- Centers of Excellence in Regulatory Science and Innovation (CERSI)
- Office of Regulatory Science and Innovation News and Upcoming Events